Answers are grounded in this paper and cite their sources.
Shows ComicGTN improves rare cell identification in disease contexts, suggesting enhanced clinical insights.
Single-cell multiomic technology makes it possible to profile both the transcriptome and epigenome within individual cells. The detection of rare cell states from such data is crucial for exploring novel disease biomarkers with clinical potential. However, existing methods typically focus on the gene and peak counts while ignoring the underlying genomic sequence at accessible sites. Here, we propose ComicGTN, an innovative computational framework that integrates single-cell multiomic data with DNA sequence information via enhanced graph transformer networks to accurately identify rare cell clusters. ComicGTN consistently outperforms nine state-of-the-art methods in identifying rare cells across multiple complex scenarios. In mouse breast cancer data, ComicGTN detects several functionally distinct immune subpopulations. In cerebral cortex of epilepsy patients, it uncovers oligodendrocytes undergoing particular differentiation states. For polycystic kidney disease patient–derived organoids, ComicGTN elaborates pathological pathways in a captured rare glomerular subgroup. Overall, ComicGTN accelerates the localization of disease-associated rare cell populations, facilitating the derivation of clinical insights in development and disease progression.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: